MyAverix Finance
HK · Healthcare
Jw Cayman Therapeutics Co Ltd (2126)
Biotechnology
Jw Cayman Therapeutics Co Ltd (2126) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $862.10M, P/E ratio is 18.00, net margin is -195.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2126
Jw Cayman Therapeutics Co Ltd (2126) — FAQ
What is Jw Cayman Therapeutics Co Ltd's market cap?
Jw Cayman Therapeutics Co Ltd (2126) has a reported market cap of $862.10M (data as of 2026-05-21).
What is 2126's P/E ratio?
The price-to-earnings (P/E) ratio for Jw Cayman Therapeutics Co Ltd (2126) is 18.00 (data as of 2026-05-21).
Does Jw Cayman Therapeutics Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jw Cayman Therapeutics Co Ltd (2126). Check the MyAverix Finance app for the latest dividend data.
What sector is Jw Cayman Therapeutics Co Ltd in?
Jw Cayman Therapeutics Co Ltd (2126) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2126 listed on?
2126 is listed on HK.
What is Jw Cayman Therapeutics Co Ltd's net margin?
Jw Cayman Therapeutics Co Ltd (2126) reports a net margin of -195.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.